TCR2 Therapeutics
Why Robinhood?
You can watch TCRR and buy or sell other stocks, ETFs, and their options commission-free!About TCRR
TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development.
TCRR Key Statistics
Stock Snapshot
With a market cap of 58.11M, TCR2 Therapeutics(TCRR) trades at $1.48. The stock has a price-to-earnings ratio of -0.35.
On 2026-04-03, TCR2 Therapeutics(TCRR) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for TCR2 Therapeutics(TCRR) stock has reached 0, versus its average volume of 694.31K.
The stock's 52-week range extends from a low of $0.82 to a high of $3.88.
The stock's 52-week range extends from a low of $0.82 to a high of $3.88.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.